Commonwealth Equity Services, Inc - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q2 2016$289,000
+6.2%
1,984
+4.6%
0.00%0.0%
Q1 2016$272,000
-22.7%
1,897
-16.7%
0.00%
-33.3%
Q4 2015$352,000
+4.8%
2,277
-3.2%
0.00%
-25.0%
Q3 2015$336,000
+33.3%
2,352
+33.9%
0.00%
+33.3%
Q2 2015$252,000
+1.6%
1,7570.0%0.00%0.0%
Q1 2015$248,0001,7570.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2016
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders